These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6146746)

  • 21. The role of alpha-adrenoceptor blockade in the treatment of hypertension.
    Abrams SM; Turner P
    J Clin Hosp Pharm; 1983 Jun; 8(2):175-81. PubMed ID: 6135715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New findings on the use of specific alpha-1 adrenergic blockers in the treatment of high blood pressure].
    Horký K
    Vnitr Lek; 1991 Jun; 37(6):604-11. PubMed ID: 1680257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension.
    Chang PC; Kriek E; van Brummelen P
    J Hypertens; 1994 Feb; 12(2):179-90. PubMed ID: 8021470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacological basis for the use of alpha 1-adrenoceptor antagonists in the treatment of essential hypertension.
    Davey MJ
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):5S-8S. PubMed ID: 2871856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-adrenoceptor blocking drugs and their use in hypertension.
    Prichard NC
    S Afr Med J; 1976 Nov; 50(47):1902-9. PubMed ID: 12577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The pharmacodynamic and hypotensive efficacy of proxodolol in an acute drug test on hypertension patients].
    Kukes VG; Starodubtsev AK; Smirnov MV; Petrov IN
    Eksp Klin Farmakol; 1994; 57(3):45-7. PubMed ID: 7914120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality?
    Tahmatzopoulos A; Kyprianou N
    Prostate; 2004 Apr; 59(1):91-100. PubMed ID: 14991869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha- and beta-receptor blocking drugs in the treatment of hypertension.
    Ram CV; Kaplan NM
    Curr Probl Cardiol; 1979 Jan; 3(10):1-53. PubMed ID: 40755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The renaissance of centrally acting antihypertensive drugs.
    van Zwieten PA
    J Hypertens Suppl; 1999 Aug; 17(3):S15-21. PubMed ID: 10489094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group.
    Na YJ; Guo YL; Gu FL
    J Med; 1998; 29(5-6):289-304. PubMed ID: 10503165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical application of adrenoceptor blockers in the treatment of hypertension].
    Mikami H; Ogihara T
    Nihon Rinsho; 1989 Sep; 47(9):2035-40. PubMed ID: 2574242
    [No Abstract]   [Full Text] [Related]  

  • 32. New perspectives in cardiopulmonary therapeutics: receptor-selective adrenergic drugs.
    Adams HR
    J Am Vet Med Assoc; 1984 Nov; 185(9):966-74. PubMed ID: 6150925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in the acute and chronic antihypertensive mechanism of action of ketanserin in spontaneously hypertensive rats.
    Balasubramaniam G; Lee HS; Mah SC
    J Pharmacol Exp Ther; 1993 Jan; 264(1):129-34. PubMed ID: 8093720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. History and nomenclature of alpha1-adrenoceptors.
    Langer SZ
    Eur Urol; 1999; 36 Suppl 1():2-6. PubMed ID: 10438241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naloxone-induced potentiation of cardiac alpha-2 adrenoceptor-mediated depression of neurogenic tachycardia.
    Slavik KJ; Szilagyi JE
    J Pharmacol Exp Ther; 1993 Jul; 266(1):184-91. PubMed ID: 8101216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presynaptic regulation of the release of catecholamines.
    Langer SZ
    Pharmacol Rev; 1980 Dec; 32(4):337-62. PubMed ID: 6267618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alteration in alpha- and beta-adrenoceptor profile of rabbit knee joint blood vessels due to acute inflammation.
    Najafipour H
    Exp Physiol; 2000 May; 85(3):267-73. PubMed ID: 10825413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS; Takakura AC; Menani JV; Colombari E
    Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
    Hopkins BJ; Hodgson WC; Sutherland SK
    Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-adrenergic blocking agents in the treatment of hypertension. Choices based on pharmacological properties and patient characteristics.
    Wallin JD; Shah SV
    Arch Intern Med; 1987 Apr; 147(4):654-9. PubMed ID: 2881524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.